53 related articles for article (PubMed ID: 970015)
1. [A Czechoslovak injection-contraceptive agent administered once a month].
Stĕrba R
Zentralbl Gynakol; 1976; 98(3):158-60. PubMed ID: 970015
[TBL] [Abstract][Full Text] [Related]
2. Bleeding patterns of adolescents using a combination contraceptive injection for 1 year.
Bortolotti de Mello Jacobucci MS; Guazzelli CA; Barbieri M; Araújo FF; Moron AF
Contraception; 2006 Jun; 73(6):594-7. PubMed ID: 16730490
[TBL] [Abstract][Full Text] [Related]
3. [New perspectives for injectable contraceptives].
v Kesserü E
Adv Contracept; 1994 Jul; 10 Suppl 1():69-77. PubMed ID: 7839874
[No Abstract] [Full Text] [Related]
4. Once-a-month injectable contraceptives.
d'Arcangues C
World Health Forum; 1993; 14(4):439-40. PubMed ID: 8185807
[TBL] [Abstract][Full Text] [Related]
5. The effects of long-term using once-a-month injectable contraceptive norethisterone enanthate/estradiol valerate on coagulation in the Chinese.
Meng YX; Jiang HY; Lu FY
Thromb Haemost; 1990 Dec; 64(4):548-9. PubMed ID: 2084940
[TBL] [Abstract][Full Text] [Related]
6. Expanding contraceptive choices: lunelle monthly contraceptive injection.
Shulman LP
Int J Fertil Womens Med; 2000; 45(2):190-4. PubMed ID: 10831189
[TBL] [Abstract][Full Text] [Related]
7. [Injectable contraceptives. 10 years' clinical experience].
Cervantes A; Gorodovsky J; Maqueo M
Ginecol Obstet Mex; 1973 Oct; 34(204):369-81. PubMed ID: 4272910
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of the effects of two once-a-month injectable steroidal contraceptives (Mesigyna and Cyclofem) on lipid and lipoprotein metabolism. United Nations Development Programme/United Nations Population Fund/World Health Organization/World Bank, Special Programme of Research, Development and Research Training in Human Reproduction.
Contraception; 1997 Oct; 56(4):193-207. PubMed ID: 9408700
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of the effects of two once-a-month injectable steroidal contraceptives (Mesigyna and Cyclofem) on glucose metabolism and liver function. United Nations Development Programme/United Population Fund/World Health Organization/World Bank, Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-acting Systemic Agents for Fertility Regulation.
Contraception; 1998 Feb; 57(2):71-81. PubMed ID: 9589832
[TBL] [Abstract][Full Text] [Related]
10. Monthly injectable contraceptive use by adolescents in Brazil: evaluation of clinical aspects.
Guazzelli CA; Jacobucci MS; Barbieri M; Araújo FF; Moron AF
Contraception; 2007 Jul; 76(1):45-8. PubMed ID: 17586136
[TBL] [Abstract][Full Text] [Related]
11. [Use and effectiveness of norethisterone enanthate for family planning in a rural area].
Velasco Murillo V; Ortiz López J; García López E; Correu Azcona S
Ginecol Obstet Mex; 1983 Jun; 51(314):163-7. PubMed ID: 6681299
[TBL] [Abstract][Full Text] [Related]
12. Hormonal contraceptive discontinuation patterns according to formulation: investigation of associations in an administrative claims database.
Murphy PA; Brixner D
Contraception; 2008 Apr; 77(4):257-63. PubMed ID: 18342648
[TBL] [Abstract][Full Text] [Related]
13. Depo Provera. Position paper on clinical use, effectiveness and side effects.
Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
[TBL] [Abstract][Full Text] [Related]
14. Comparative evaluation of two once-a-month contraceptive injections.
Kazi AI
J Pak Med Assoc; 1989 Apr; 39(4):98-102. PubMed ID: 2526239
[TBL] [Abstract][Full Text] [Related]
15. Bone mineral density in users of two kinds of once-a-month combined injectable contraceptives.
Bahamondes L; Juliato CT; Villarreal M; Sobreira-Lima B; Simões JA; dos Santos Fernandes AM
Contraception; 2006 Sep; 74(3):259-63. PubMed ID: 16904421
[TBL] [Abstract][Full Text] [Related]
16. Comparative performance of a combined injectable contraceptive (50 mg norethisterone enanthate plus 5mg estradiol valerate) and a combined oral contraceptive (0.15 mg levonorgestrel plus 0.03 mg ethinyl estradiol) in adolescents.
Molina RC; Sandoval JZ; Montero AV; Oyarzún PG; Molina TG; González EA
J Pediatr Adolesc Gynecol; 2009 Feb; 22(1):25-31. PubMed ID: 19232299
[TBL] [Abstract][Full Text] [Related]
17. Clinical trial of intramuscular injection as contraceptive compound.
Lay CL
Med Gynaecol Sociol; 1970; 5():7-9. PubMed ID: 12305458
[TBL] [Abstract][Full Text] [Related]
18. Menstrual pattern and lipid profiles during use of medroxyprogesterone acetate and estradiol cypionate and NET-EN (200 mg) as contraceptive injections.
Canto de Cetina TE; Luna MO; Cetina Canto JA; Bassol S
Contraception; 2004 Feb; 69(2):115-9. PubMed ID: 14759615
[TBL] [Abstract][Full Text] [Related]
19. New aspects of injectable contraception.
Phillips OP
Int J Fertil Womens Med; 2001; 46(1):31-6. PubMed ID: 11294618
[TBL] [Abstract][Full Text] [Related]
20. Demographic analysis of post-abortive and interval-administered hormonal contraceptive methods.
Ertopçu K; Inal MM; Ozelmas I
Eur J Contracept Reprod Health Care; 2005 Mar; 10(1):1-5. PubMed ID: 16036290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
